1.	Phase III Pilot Chemotherapy with Short-Course ProMACE-CytaBOM (CTX/ADR/VP-16/ARA-C/BLEO/VCR/MTX/PRED) for the Treatment of Patients with Stages II-IV Diffuse Aggressive Lymphomas Phase: Phase III Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: CRB-8807E, NCI-87-C-180C, NCI-T87-0307N, T87-0307
2.	Phase I/II Pilot Study of Cytotoxic Chemotherapy with CTX/DOX/VP-16/VCR/MTX/CF plus Recombinant GM-CSF, AZT, and Inhaled Pentamidine in Patients with AIDS-Associated non-Hodgkin's Lymphoma (Summary Last Modified 06/90) Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-90-C-34, NCI-MB-249, NCI-T89-0194N, T89-0194
3.	Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma Phase: Phase II Type: Treatment Status: Completed Age: over 15 Sponsor: NCI, Other Protocol IDs: DM93-058, P30CA016672, MDA-DM-93058, NCI-T93-0088D, CDR0000078316, T93-0088, NCT00002524